2024
The CCRA responds to the engagement request on Federal research support restructuring.
The CCRA renames its “Exceptional Leadership in Cancer Research Award” to the “Philip E. Branton Award for Exceptional Leadership in Cancer Research” to acknowledge and recognize Dr. Branton’s pivotal role in the creation of CCRA and his extraordinary contribution to Canada’s cancer research community.
New Patient/Family Representative on the CCRA Advisory Board
Effective January 1st, 2024, CCRA welcomes Dr. Rosilene Kraft as the incoming patient/family representative on the CCRA Advisory Board. Most recently, Rosilene served on the 2023 PIP Working Committee and was cross-appointed to the conference Scientific Program Committee. Sh... Read More »
Effective January 1st, 2024, CCRA welcomes Dr. Rosilene Kraft as the incoming patient/family representative on the CCRA Advisory Board. Most recently, Rosilene served on the 2023 PIP Working Committee and was cross-appointed to the conference Scientific Program Committee. Sh... Read More »
Are you a cancer patient, survivor, or caregiver who is interested in learning more about cancer research?
CCRA’s Patient Involvement in Cancer Research Program (known as PIP) will be offered this year as an in-person program. PIP is interwoven with the Canadian Cancer Research Confere... Read More »
CCRA’s Patient Involvement in Cancer Research Program (known as PIP) will be offered this year as an in-person program. PIP is interwoven with the Canadian Cancer Research Confere... Read More »